Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
The IND application supports the next phase of development of SBO-154
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
Positions Curium as leading manufacturer of Lu-177 isotope
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Subscribe To Our Newsletter & Stay Updated
